New pill aims to clear skin and improve life for psoriasis patients

NCT ID NCT07326813

Summary

This study is testing an investigational oral medication called D-2570 for people with moderate to severe plaque psoriasis. It will compare the new drug's effectiveness and safety against a placebo (a dummy pill) and an existing approved medication. The goal is to see if D-2570 can better reduce skin symptoms and improve quality of life for participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai Skin Disease Hospital

    Shanghai, Shanghai Municipality, 200443, China

Conditions

Explore the condition pages connected to this study.